Indiana_Trial 02

Investigation of an Investigational Treatment for Hypertension

P
PRINCIPLE INVESTIGATOR

Primary Investigator

Indiana_Trial 02
Recruiting
18 years - 100 years
Transgender
Phase 2
120 participants needed
2 Locations

Brief description of study.

Test Comment here

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acne
  • Age: 18 years - 100 years
  • Gender: Transgender

Inclusion Criteria:
Exclusion Criteria:

Updated on 19 Feb 2024. Study ID: TX11232
  • Who can participate: Adults aged 18 to 65 with a diagnosis of hypertension may be eligible. Key exclusions include those with secondary hypertension or recent cardiovascular events.
  • Study details: Participants will receive either the investigational medication or a placebo, administered orally once daily. The placebo is an inactive substance designed to mimic the investigational treatment.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here